Globe Life offers a mix of life and health insurance products, with growth recently centered around health insurance. Q2 2025 results were solid on both a GAAP and operating income basis, prompting ...

Globe Life (NYSE:GL) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table below ...

Although Globe Life executives acknowledged that the insurer remains the target of several investigations, little else went wrong in strong second quarter. The McKinney, Texas-based company reported ...

Morgan Stanley analyst Bob Huang lowered the firm’s price target on Globe Life (GL) to $176 from $177 and keeps an Overweight rating on the ...